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WS11.1 Role of short chain fatty acids produced by anaerobic
bacteria in cystic ﬁbrosis
M.A. Murray1, D.A. Bergin1, E.P. Reeves1, N.G. McElvaney1. 1Royal College of
Surgeons in Ireland, Medicine, Dublin, Ireland
Rationale: Chronic bacterial infection leading to an irreversible decline in lung
function is the main cause of mortality and morbidity in people with cystic ﬁbrosis
(CF). Anaerobic bacteria have been recently shown to be present in sputum in
high numbers in CF; however their role in infection and inﬂammation needs further
investigation. Short chain fatty acids (SCFA) are known to be produced as metabolic
by-products of anaerobic bacteria and we investigated if their role in initiating the
pro-inﬂammatory cascade.
Objectives: To investigate the role SCFAs play in the CF lung and if they are
pro-inﬂammatory mediators.
Methods and Results: We investigated the protein and mRNA expression levels
of GPR41 and GPR 43, G protein coupled receptors for SCFAs, using Western blot
analysis and reverse transcriptase-polymerase chain reaction. We found that GPR41
and GPR 43 protein and mRNA are highly expressed in cystic ﬁbrosis bronchial
epithelial cells, (CFBE 41o) as compared with normal human bronchial epithelial
cells (16HBE14o) and this was shown to be signiﬁcant (p< 0.001).
We evaluated the role of IL-8 production by quantifying the most known prevalent
SCFA, sodium butyrate on CFBE 41o and 16HBE14o using enzyme-linked-linked
immunosorbent assay (ELISA). We found increased IL-8 production in CFBE cells
compared to HBE cells.
Conclusion: We found differentiated increased expression of GPR 41 in CFBE
41o cells compared with 16HBE14o. We also found that sodium butyrate, a SCFA,
increases IL-8 production in CFBE cells.
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Pseudomonas aeruginosa is the predominant cause of mortality in cystic ﬁbro-
sis (CF) patients. Once established, eradication of this pathogen from the lungs is
almost impossible due to its natural resistance to antibiotics and its bioﬁlm-like
mode of growth. Bioﬁlms are dynamic, three-dimensional communities of bacteria
living in an extracellular polysaccharide matrix that is relatively impenetrable to
antibiotics. In this study, a mutant library for the clinical P. aeruginosa strain PA14
was used to identify genes involved in bioﬁlm formation. From the >5200 mutants
screened, 30 genes involved in the disruption of bioﬁlm formation in artiﬁcial
sputum media were identiﬁed. One of these genes, a LysR-type transcriptional
regulator (LTTR) was further characterised. Interestingly, Type Three Secretion and
motility were affected by this LTTR, but more importantly it also appeared to
play a key role in pathogenicity in the C. elegans model of infection. Extensive
analysis, including transcriptome, and whole proteome analysis using the LTQ
Orbitrap mass spectrometer have been performed. The data generated from these
studies is currently being interrogated in order to identify the molecular mechanisms
underpinning these key virulence traits. Mechanisms identiﬁed could be exploited
to develop novel therapeutic strategies to combat chronic P. aeruginosa infection in
the CF lung.
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Pseudomonas aeruginosa induces lung injury in numerous diseases including cystic
ﬁbrosis (CF). The host cytosolic phospholipase A2a (cPLA2a) releases arachidonic
acid (AA), the precursor of prostaglandin E2 (PGE2), but its role in lung injury
by P. aeruginosa infection is unknown. Here, we examined this role in a mouse
model of lung infection by a clinical strain (CHA) of P. aeruginosa. We showed
that CHA increased mouse mortality, PMN extravasation and cytokine levels in
bronchoalveolar lavage ﬂuids (BALFs). This was accompanied by increased protein
and LDH levels in BALFs. cPLA2a-null mutation reduced both animal mortality,
protein and LDH levels without interfering with PMN and cytokine levels. CHA
triggered cPLA2a phosphorylation in parallel to AA, PGE2 and LDH release in lung
epithelial cell line A549 through an activation of the p38-MAPK. Pharmacological
inhibition of cPLA2a attenuated CHA-induced AA, PGE2 and LDH release, but had
no effect on IL-8 secretion by A549 cells. Finally, we examined the role of cPLA2a
in CHA-induced mortality in CF mice previously shown to display increased
pulmonary cPLA2a activity. CHA induced higher mortality in CF compared to
non-CF mice. Inhibition of cPLA2a attenuated CHA-induced CF mice mortality
without interfering with lung inﬂammation. We conclude that cPLA2a plays a role
in P. aeruginosa-induced lethality independently from lung inﬂammation and in
part via a cPLA2a-induced toxicity. These ﬁndings might have pathophysiological
relevance for CF or other P. aeruginosa lung infections.
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Cystic ﬁbrosis (CF) lung disease is characterized by transient airway P. aeruginosa
infections and excessive neutrophil-dominated inﬂammation early in life followed
by permanent chronic infection leading to the decline in lung functions. Here we
aimed to dissect the host response to P. aeruginosa patho-adaptive strains during
acute and chronic infection.
Sequential clonal strains isolated from a CF patient during a period of up to 7.5 years
were tested in IB3−1 CF and C38 isogenic wt cells, macrophage-like cells THP-1
and mouse models. Microarray analysis and ELISA of infected cells showed a
decreased inﬂammatory response, including down-regulation of leukocyte receptors
and adhesion molecules, and an increased damage mediated by tissue remodelling,
due to late strains compared to early strains.
In murine model of acute infection, the early P. aeruginosa strain induced higher
mortality than late clonal strains. Although attenuated in mortality, P. aeruginosa
late strains retained their capacity to persist in mouse models of chronic infection,
induced leukocytes recruitment, and stimulated pro-inﬂammatory cytokines and
chemokines production (MIP-2, KC, TNF-a, IL-17, IFN-g, MCP-1, TGF-b) up to
one month from challenged. H&E, PAS- and MTS-staining, and Tunnel assay of
P. aeruginosa-infected lungs showed that late strains increased numbers of mucin-
positive goblet cells, collagen deposition and apoptotic cells, typical hallmarks of
damage in the airway chronic diseases.
Our ﬁndings suggest that P. aeruginosa patho-adaptive variants, although less
inﬂammatory or lethal, can promote persistence while causing damage and ﬁbrosis
in the airway of chronic disease.
